IP Library › Granted Patent US 9,345,718
Granted Patent B1
US 9,345,718 · App. 14/934,209 · Granted May 24, 2016

Phospholipid ether analogs as cancer-targeting drug vehicles

Inventors: Jamey P. Weichert (Fitchburg, WI); Anatoly Pinchuk (Fitchburg, WI); Kevin Kozak (Madison, WI); Marc Longino (Verona, WI); Joseph Grudzinski (Madison, WI); Benjamin Titz (Madison, WI); Chorom Pak (Madison, WI); Nathan Stehle (Madison, WI)
Assignee: CELLECTAR BIOSCIENCES, INC.
A61K31/665
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,345,718
App. No.
14/934,209
Granted
May 24, 2016
Kind
B1
Abstract

The present invention is directed to therapeutic compounds capable of targeting cancer cells and cancer stem cells. The present invention is further directed to compositions comprising these therapeutic compounds and methods of treating cancer comprising administering these therapeutic compounds.

Claims (2)

1. A therapeutic compound of Formula (V),

2. A pharmaceutical composition comprising a therapeutic compound of claim 1 and one or more pharmaceutically acceptable carriers.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2017
From: WEICHERT, JAMEY P.; PINCHUK, ANATOLY; KOZAK, KEVIN; LONGINO, MARC; GRUDZINSKI, JOSEPH; TITZ, BENJAMIN; PAK, CHOROM; STEHLE, NATHAN
To: CELLECTAR BIOSCIENCES, INC.
Reel/Frame 043915/0001 →
Continuity (1)
Provisional Application 62080436 · Nov 17, 2014